Clinical Trial
Patient-derived organoid model and circulating tumor cells for treatment response of lung cancer
Create a living biobank of PDOs from Stage I-III lung cancer patients.
Create a living biobank of PDOs from Stage I-III lung cancer patients.
NRG-BN013 is an unblinded, randomized phase III trial to determine if the time to local failure is significantlylonger with FSRS compared to SRS in patients with intact brain metastasis.